secwatch.observer — SEC 8-K summary
======================================

Issuer:     Q/C TECHNOLOGIES, INC. (QCLS)
CIK:        0001321834
Form:       8-K
Filed at:   2023-02-21T23:59:59+00:00
Accession:  0001493152-23-005585
Event type: other_material
Sentiment:  positive
Materiality: 0.70
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

MyMD raises $15M in registered direct offering of convertible preferred stock and warrants
--------------------------------------------------------------------------------

- Gross proceeds of $15M from sale of Series F Convertible Preferred Stock and warrants to accredited/institutional investors.
- Conversion/exercise price of $2.255 per share, ~10% premium to Feb 17 closing price.
- Warrants exercisable immediately at $2.255, expire in 5 years; preferred stock convertible at same price.
- Proceeds to fund development of MYMD-1 for sarcopenia (Phase 2) and rheumatoid arthritis.
- Closing expected Feb 23, 2023; Katalyst Securities as placement agent.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1321834/000149315223005585/0001493152-23-005585-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1321834/000149315223005585/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-005585

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer